Submission Details
| 510(k) Number | K223711 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 12, 2022 |
| Decision Date | August 10, 2023 |
| Days to Decision | 241 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K223711 is an FDA 510(k) clearance for the ANNE One, a Transmitters And Receivers, Physiological Signal, Radiofrequency (Class II — Special Controls, product code DRG), submitted by Sibel Health, Inc. (Niles, US). The FDA issued a Cleared decision on August 10, 2023, 241 days after receiving the submission on December 12, 2022. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2910.
| 510(k) Number | K223711 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 12, 2022 |
| Decision Date | August 10, 2023 |
| Days to Decision | 241 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DRG — Transmitters And Receivers, Physiological Signal, Radiofrequency |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2910 |